| |
 |
|
Class Information
Number: 514/200
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)
Description:
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5484809 |
Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid |
Jan. 16, 1996 |
| 5460813 |
Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin |
Oct. 24, 1995 |
| 5439904 |
2-spiro(2'-spirocycloalkyl)cyclopropyl cephalosporin sulfones as antiinflammatory and antigenerative agents |
Aug. 8, 1995 |
| 5411947 |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
May. 2, 1995 |
| 5409917 |
Topical treatment of acne with cephalosporins |
Apr. 25, 1995 |
| 5395842 |
Anti-estrogenic compounds and compositions |
Mar. 7, 1995 |
| 5374633 |
Imidazole dermal penetration enhancers |
Dec. 20, 1994 |
| 5356888 |
1,1-dioxo-cephem-4-carbothiolic acid derivatives |
Oct. 18, 1994 |
| 5350680 |
Cephalosporinase testing agent |
Sep. 27, 1994 |
| 5312813 |
Biofilm reduction method |
May. 17, 1994 |
| 5264346 |
Colorimetric method for beta-lactamase assay and its applications |
Nov. 23, 1993 |
| 5256684 |
Methods and compositions for the treatment of gastrointestinal disorders |
Oct. 26, 1993 |
| 5198419 |
Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria |
Mar. 30, 1993 |
| 5192752 |
Swallowable pharmaceutical compositions containing Colloidal Bismuth Subcitrate |
Mar. 9, 1993 |
| 5190748 |
Absorption enhancement of antibiotics |
Mar. 2, 1993 |
| 5114929 |
Pharmaceutical formulation |
May. 19, 1992 |
| 5008257 |
Brain-specific drug delivery |
Apr. 16, 1991 |
| 4992422 |
Compositions comprising 1-substituted azacycloalkanes |
Feb. 12, 1991 |
| 4956358 |
Tricyclic cepham compounds and use |
Sep. 11, 1990 |
| 4861768 |
2 .beta.-substituted thiomethylpenicillin derivatives and their preparation and use |
Aug. 29, 1989 |
| 4803196 |
Pharmaceutical compositions containing .beta.-lactam antibiotics |
Feb. 7, 1989 |
| 4760059 |
Rectal dosage form |
Jul. 26, 1988 |
| 4760060 |
3-heteroaralkylthio carbacephem compounds and antibacterial pharmaceutical composition |
Jul. 26, 1988 |
| 4749694 |
Novel lysine esters used as absorption |
Jun. 7, 1988 |
| 4735937 |
8-oxo-5-thia-1-azabicyclo(4,2,0)oct-2-ene compounds |
Apr. 5, 1988 |
| 4732753 |
Suppository dosage form |
Mar. 22, 1988 |
| 4731360 |
Acylcarnitines as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal compartments |
Mar. 15, 1988 |
| 4729989 |
Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts |
Mar. 8, 1988 |
| 4725591 |
.beta.-lactamase inhibitory composition |
Feb. 16, 1988 |
| 4713247 |
Long-acting formulation of cefaclor |
Dec. 15, 1987 |
| 4695467 |
Sustained release tablet |
Sep. 22, 1987 |
| 4692441 |
Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities |
Sep. 8, 1987 |
| 4678781 |
3-substituted-aminomethyl cephalosporin derivatives |
Jul. 7, 1987 |
| 4668504 |
Use of substituted propenoates to prevent nephrotoxicity of certain antibiotics |
May. 26, 1987 |
| 4666899 |
3-(Optionally substituted-but-1-en-3-ynyl) cephalosporins |
May. 19, 1987 |
| 4637999 |
Substituted cephalosporins as anti-inflammatory and antidegenerative agents |
Jan. 20, 1987 |
| 4631274 |
Halovinyl cephem compounds |
Dec. 23, 1986 |
| 4626535 |
Cephalosporins |
Dec. 2, 1986 |
| 4623645 |
Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents |
Nov. 18, 1986 |
| 4622318 |
3-(substituted-ethenyl or ethynyl-thiomethyl) cephems |
Nov. 11, 1986 |
| 4619925 |
3-Propenyl cephalosporin derivatives |
Oct. 28, 1986 |
| 4616008 |
Antibacterial solid composition for oral administration |
Oct. 7, 1986 |
| 4605651 |
Antibiotic amino acid derivatives of cephalosporins |
Aug. 12, 1986 |
| 4604386 |
3-(alkynylalkyloxy) cephalosporins |
Aug. 5, 1986 |
| 4603050 |
Method for medical treatment of bone tissue defects |
Jul. 29, 1986 |
| 4594246 |
Pharmaceutically-acceptable amine salts of 6-.beta.-halopenicillanic acids |
Jun. 10, 1986 |
| 4571334 |
Composition for curing respiratory diseases |
Feb. 18, 1986 |
| 4563522 |
Cephem compounds |
Jan. 7, 1986 |
| 4547371 |
Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents |
Oct. 15, 1985 |
| 4525339 |
Enteric coated oral dosage form |
Jun. 25, 1985 |
|
|
|
